Citations (154)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Raju Samala, Satheesh Kumar Nukala, Narasimha Swamy Thirukovela, Gouthami Dasari & Srinivas Bandari. (2023) One-Pot Synthesis of Some New Phthalazine-Piperazine-1,2,4-Oxadiazole Hybrids: Anticancer Evaluation, Molecular Docking and ADMET Studies. Polycyclic Aromatic Compounds 43:10, pages 9175-9192.
Read now
Read now
Srimathi Kurma, Satheesh Kumar Nukala, Narasimha Swamy Thirukovela, Vinitha Badithapuram, Gouthami Dasari & Srinivas Bandari. (2023) Design and Synthesis of Some New Quinoxaline-1,2,4-Oxadiazole-Amide Conjugates as EGFR Targeting Agents and ADMET Studies. Polycyclic Aromatic Compounds 0:0, pages 1-14.
Read now
Read now
Subbareddy Lavunuri, Ratnakaram Venkata Nadh & Siva Kumar Rapeti. (2023) Anti-Proliferative, Anti-EGFR and In Silico Studies of a Series of New Imidazole Tethered 1,2,4-Oxadiazoles. Polycyclic Aromatic Compounds 0:0, pages 1-14.
Read now
Read now
Claudiu T. Supuran. (2021) Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1702-1714.
Read now
Read now
Reem I Al-Wabli, Aliyah A Almomen, Maha S Almutairi, Adam B Keeton, Gary A Piazza & Mohamed I Attia. (2020) New Isatin–Indole Conjugates: Synthesis, Characterization, and a Plausible Mechanism of Their in vitro Antiproliferative Activity. Drug Design, Development and Therapy 14, pages 483-495.
Read now
Read now
Sumit Kumar, Nishant Verma, Nikhil Kumar, Alok Patel, Partha Roy, Vikas Pruthi & Naseem Ahmed. (2016) Design, synthesis, molecular docking, and biological studies of novel phytoestrogen-tanaproget hybrids. Synthetic Communications 46:5, pages 460-474.
Read now
Read now
Alberto Leoni, Alessandra Locatelli, Rita Morigi & Mirella Rambaldi. (2016) 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008–2014). Expert Opinion on Therapeutic Patents 26:2, pages 149-173.
Read now
Read now
Hala Bakr El-Nassan. (2015) Synthesis and antitumor activity of tetrahydrocarbazole hybridized with dithioate derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry 30:2, pages 308-315.
Read now
Read now
Sébastien Fortin & Gervais Bérubé. (2013) Advances in the development of hybrid anticancer drugs. Expert Opinion on Drug Discovery 8:8, pages 1029-1047.
Read now
Read now
Varvara Pokrovskaya & Timor Baasov. (2010) Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance. Expert Opinion on Drug Discovery 5:9, pages 883-902.
Read now
Read now
T. Shreedhar Reddy, Sanjay Rai & Shiva Kumar Koppula. Synthesis of 4-Azaindole-Thiazolidine-2,4-Dione Coupled 1,2,3-Triazoles as EGFR Directing Anticancer Agents. Polycyclic Aromatic Compounds 0:0, pages 1-13.
Read now
Read now
Articles from other publishers (143)
Sandhya Rani Bandi, Ravikumar Kapavarapu, Rambabu Palabindela, Mohammad Azam, Kim Min & Sirassu Narsimha. (2023) Synthesis of novel pyrido[2,3-d]pyrimidine-thiazolidine-1,2,3-triazoles: Potent EGFR targeting anticancer agents. Journal of Molecular Structure 1294, pages 136451.
Crossref
Crossref
Donia Bensalah, Nasser Amri, Yousef E. Mukhrish, Waleed S. Koko & Naceur Hamdi. (2023) Synthesis and pharmacological properties of coumarin‐chalcones. MethodsX 11, pages 102488.
Crossref
Crossref
Zeguo Fang, Wen Liu, Nawaf Al-Maharik, Ruizhe Cao, Yingxue Huang, Yiting Yuan, Qian Zhang & Dong Li. (2023) Silver-Catalyzed Cascade Radical Bicyclization Reaction: An Atom- and Step-Economical Strategy Accessing γ-Lactam Containing Isoquinolinediones. The Journal of Organic Chemistry 88:21, pages 15428-15436.
Crossref
Crossref
Sonam Grewal, Teenu Sharma & Rajan Swami. (2023) New era of nanoparticles facilitated co-delivery in cancer therapy: two heads are better than one. Journal of Nanoparticle Research 25:9.
Crossref
Crossref
Elena Marchesi, Daniela Perrone & Maria Luisa Navacchia. (2023) Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates. Pharmaceutics 15:9, pages 2185.
Crossref
Crossref
Advaitha Vanaparthy, Karthik Bokkala, Narasimha Swamy Thirukovela, Narsimha Sirassu, Ravinder Manchal, Bandari Srinivas & Satheesh Kumar Nukala. (2023) Ring‐B Modification of Combretastatin A‐4 to Generate Thiazolidine‐2,4‐dione‐1,2,3‐triazole Hybrids as Tubulin Polymerization Inhibitors. ChemistrySelect 8:23.
Crossref
Crossref
Burçin Vurucu, Samet Mert, Serkan Koldaş, İbrahim Demirtaş & Rahmi Kasımoğulları. (2023) Design, synthesis and biological evaluation of novel pyrazole derivatives bearing sulfonamide scaffold as antiproliferative agents. Journal of the Iranian Chemical Society 20:5, pages 1107-1118.
Crossref
Crossref
Samia M. Al-Muntaser, Ahmed A. Al-Karmalawy, Abeer M. El-Naggar, Ali Khalil Ali, Nour E. A. Abd El-Sattar & Eslam M. Abbass. (2023)
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and
in silico
studies
. RSC Advances 13:18, pages 12184-12203.
Crossref
Crossref
Rima D. Alharthy, Faisal Rashid, Abida Ashraf, Zahid Shafiq, Steven Ford, Mariya al-Rashida, Muhammad Yaqub & Jamshed Iqbal. (2023) Pyrazole derivatives of pyridine and naphthyridine as proapoptotic agents in cervical and breast cancer cells. Scientific Reports 13:1.
Crossref
Crossref
Mallikarjuna Bangaru, Satheesh Kumar Nukala, Praveen Kumar Kannekanti, Narsimha Sirassu, Ravinder Manchal & Narasimha Swamy Thirukovela. (2023) Synthesis of Quinoline‐Thiazolidine‐2,4‐dione Coupled Pyrazoles as in vitro EGFR Targeting Anti‐Breast Cancer Agents and Their in silico Studies. ChemistrySelect 8:12.
Crossref
Crossref
Vinitha Badithapuram, Satheesh Kumar Nukala, Gouthami Dasari, Narasimha Swamy Thirukovela & Srinivas Bandari. (2023) Synthesis of Some New Phthalazine−piperazine−pyrazole Conjugates; In vitro Anti‐Cancer, ADMET And Molecular Docking Studies. ChemistrySelect 8:10.
Crossref
Crossref
Sandra Ardevines, Eugenia Marqués-López & Raquel P. Herrera. (2023) Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives. Current Medicinal Chemistry 30:10, pages 1145-1174.
Crossref
Crossref
T. Shreedhar Reddy, Sanjay Rai & Shiva Kumar Koppula. (2023) One‐Pot Synthesis of Isatin‐Pyrazole Hybrids as VEGFR‐2 Inhibitors and Molecular Docking Studies. ChemistrySelect 8:5.
Crossref
Crossref
Annapurna Mamidala, Karthik Bokkala, Narasimha Swamy Thirukovela, Narsimha Sirassu, Srinivas Bandari & Satheesh Kumar Nukala. (2022)
Synthesis of Quinoline‐Morpholine‐Coupled 1,2,3‐Triazole Hybrids as
In vitro
EGFR inhibitors
. ChemistrySelect 7:47.
Crossref
Crossref
Smriti Kushwaha, Jyoti Baranwal, Swastika Singh & Archana Jyoti. (2022) A Review on Green Synthesis of Biologically Active Compounds. Current Green Chemistry 9:3, pages 174-195.
Crossref
Crossref
K. Vidya. (2022) Sulfonyl-Benzoxazole Based 1,2,4-Oxadiazoles: Synthesis, In Vitro Antibacterial, Antibiofilm, and In Silico ADME Studies. Russian Journal of Bioorganic Chemistry 48:S1, pages S101-S109.
Crossref
Crossref
Sunitha Boda, Satheesh Kumar Nukala & Ravinder Manchal. (2022) Synthesis of Some New Indole-1,3,4-Oxadiazole Hybrids as Tubulin Polymerization Inhibitors. Russian Journal of Bioorganic Chemistry 48:S1, pages S136-S143.
Crossref
Crossref
Kotni Hari Gangadhar, Velaga Benarjee & Annapragada Ratnamala. (2022) Synthesis of 4‐Azaindole‐morpholine‐1,3,4‐oxadiazole Conjugates as Epidermal Growth Factor Receptor Inhibitors. ChemistrySelect 7:41.
Crossref
Crossref
Ravikumar Reddy Sagam, Satheesh Kumar Nukala, Rajkumar Nagavath, Narsimha Sirassu, Muqeed Mohammod, Ravinder Manchal & Narasimha Swamy Thirukovela. (2022) Synthesis of new morpholine-benzimidazole-pyrazole hybrids as tubulin polymerization inhibiting anticancer agents. Journal of Molecular Structure 1268, pages 133692.
Crossref
Crossref
Mariam M. Fakhry, Kazem Mahmoud, Mohamed S. Nafie, Ahmad O. Noor, Rawan H. Hareeri, Ismail Salama & Safaa M. Kishk. (2022) Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells. Pharmaceuticals 15:10, pages 1245.
Crossref
Crossref
Benarjee V, Saritha B, Hari Gangadhar K & B.V. Sailaja B. (2022) Synthesis of new 1,3,4-oxadiazole-1,4-benzoxazinone hybrids as tubulin polymerization inhibiting anticancer agents and their in silico studies. Tetrahedron 124, pages 132979.
Crossref
Crossref
V. Benarjee, B. Saritha, K. Hari Gangadhar & B.B.V. Sailaja. (2022) Synthesis of some new 1,4-benzoxazine-pyrazoles in water as EGFR targeting anticancer agents. Journal of Molecular Structure 1265, pages 133188.
Crossref
Crossref
Nayera I. Mansour, Selwan M. El-Sayed, Nadia S. El-Gohary, Naglaa I. Abdel-Aziz, Hussein I. El-Subbagh & Mariam A. Ghaly. (2022) New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study. Bioorganic Chemistry 127, pages 105966.
Crossref
Crossref
Salma M. Khirallah, Heba M. M. Ramadan, Ahmed Shawky, Safa H. Qahl, Roua S. Baty, Nada Alqadri, Amnah Mohammed Alsuhaibani, Mariusz Jaremko, Abdul-Hamid Emwas & Essa M. Saied. (2022) Development of Novel 1,3-Disubstituted-2-Thiohydantoin Analogues with Potent Anti-Inflammatory Activity; In Vitro and In Silico Assessments. Molecules 27:19, pages 6271.
Crossref
Crossref
Abdelrahman Mohamed, Mohamed Salah, Mariam Tahoun, Manuel Hawner, Ahmed S. Abdelsamie & Martin Frotscher. (2022) Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis. Journal of Medicinal Chemistry 65:17, pages 11726-11744.
Crossref
Crossref
Ilknur Babahan‐Bircan, Safiye Emirdağ, Ali Özmen, Mürüvvet Abbak, Oguejiofo T. Ujam, Ilke Demirkaya & M. Emin Günay. (2022)
A new hybrid ligand and its metal complexes from a natural plant (
Styrax officinalis
) bearing egonol, thiosemicarbazone and oxime units, and their anti‐cancer activities
. Applied Organometallic Chemistry 36:9.
Crossref
Crossref
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria Grishina, Mariusz Jaremko, Abdul-Hamid Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah & Pradeep Kumar. (2022) Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals 15:9, pages 1071.
Crossref
Crossref
Diana Becerra, Rodrigo Abonia & Juan-Carlos Castillo. (2022) Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives. Molecules 27:15, pages 4723.
Crossref
Crossref
Sunitha Boda, Satheesh Kumar Nukala & Ravinder Manchal. (2022) One‐Pot Synthesis of Some New Isatin‐1,2,4‐oxadiazole Hybrids as VEGFR‐2 Aiming Anticancer Agents. ChemistrySelect 7:26.
Crossref
Crossref
Ankit Jana, Arkadyuti Bhattacharjee, Sabya Sachi Das, Avani Srivastava, Akshpita Choudhury, Rahul Bhattacharjee, Swagata De, Asma Perveen, Danish Iqbal, Piyush Kumar Gupta, Saurabh Kumar Jha, Shreesh Ojha, Sandeep Kumar Singh, Janne Ruokolainen, Niraj Kumar Jha, Kavindra Kumar Kesari & Ghulam Md Ashraf. (2022) Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease. Molecular Neurobiology 59:6, pages 3512-3528.
Crossref
Crossref
Kishor Mazumder, Asma Aktar, Priyanka Roy, Biswajit Biswas, Md. Emran Hossain, Kishore Kumar Sarkar, Sitesh Chandra Bachar, Firoj Ahmed, A. S. M. Monjur-Al-Hossain & Koichi Fukase. (2022) A Review on Mechanistic Insight of Plant Derived Anticancer Bioactive Phytocompounds and Their Structure Activity Relationship. Molecules 27:9, pages 3036.
Crossref
Crossref
Kotni Hari Gangadhar, Velaga Benarjee & Annapragada Ratnamala. (2022) Synthesis of Coumarin‐Thiazolidine‐2,4‐dione‐Pyrazole Hybrids as Epidermal Growth Factor Receptor (EGFR)‐Targeted Agents. ChemistrySelect 7:17.
Crossref
Crossref
Mubashir Hassan, Faryal Mehwish Awan, Anam Naz, Enrique J. deAndrés-Galiana, Oscar Alvarez, Ana Cernea, Lucas Fernández-Brillet, Juan Luis Fernández-Martínez & Andrzej Kloczkowski. (2022) Innovations in Genomics and Big Data Analytics for Personalized Medicine and Health Care: A Review. International Journal of Molecular Sciences 23:9, pages 4645.
Crossref
Crossref
Wael A. El-Sayed, Fahad M. Alminderej, Marwa M. Mounier, Eman S. Nossier, Sayed M. Saleh & Asmaa F. Kassem. (2022) Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2. Molecules 27:7, pages 2047.
Crossref
Crossref
Pengcheng Lv, Yinyi Cai, Jiayi Luo & Kun Chen. (2022) Recent Advances in the Design and Synthesis of Small Molecule Carbonic
Anhydrase IX Inhibitors. Current Topics in Medicinal Chemistry 22:7, pages 550-560.
Crossref
Crossref
Venu kudapa, Saritha B & B. B. V. Sailaja. (2022) Synthesis and Anticancer Activity of Some New 4-Azaindoleisoxazoles. Russian Journal of General Chemistry 92:3, pages 470-476.
Crossref
Crossref
Chioma G. Anusionwu, Blessing A. Aderibigbe, Samson A. Adeyemi, Philemon Ubanako, Samson O. Oselusi, Yahya E. Choonara & Xavier Yangkou Mbianda. (2022) Novel ferrocenylbisphosphonate hybrid compounds: Synthesis, characterization and potent activity against cancer cell lines. Bioorganic & Medicinal Chemistry 58, pages 116652.
Crossref
Crossref
Rajkumar Nagavath, Satheesh Kumar Nukala, Narsimha Sirassu, Ravikumar Reddy Sagam, Ravinder Manchal, Suresh Paidakula & Narasimha Swamy Thirukovela. (2022) One-pot synthesis of some new regioselective 4β-pyrazolepodophyllotoxins as DNA topoisomerase-II targeting anticancer agents. Journal of Molecular Structure 1250, pages 131724.
Crossref
Crossref
Manoj Kumar N, Satheesh Kumar Nukala, Narasimha Swamy T, Ravinder M, Thupurani Murali Krishna & Sirassu Narsimha. (2022) Benzothiazole-[1,2,3]triazolo[5,1-a]isoindoles: Synthesis, anticancer activity, bioavailability and in silico studies against Gama-Tubulin protein. Journal of Molecular Structure 1250, pages 131722.
Crossref
Crossref
Madhu Sudhana Reddy Gangireddy, Vishnu Nayak Badavath, Caroline Velez, Naphat Loeanurit, Abhishek Thakur, Venkatnarayana Chowdary Maddipati, Naresh Kumar Katari, Orlando Acevedo, Siwaporn Boonyasuppayakorn & Rambabu Gundla. (2022) Discovery of 3-chlorobenzyl-linked 1,9-diazaspiro[5.5]undecane derivatives, a lead for dengue virus type 2 infection. New Journal of Chemistry 46:3, pages 1087-1098.
Crossref
Crossref
Vinitha Badithapuram, Satheesh Kumar Nukala, Narasimha Swamy Thirukovela, Ravinder Manchal, Gouthami Dasari & Srinivas Bandari. (2022) Design, Synthesis, and Anti-Proliferative Activity of Quinoxaline Linked 1,2,4-Oxadiazole Hybrids. Russian Journal of General Chemistry 92:1, pages 117-124.
Crossref
Crossref
C.G. Arya, Munugala Chandrakanth, K. Fabitha, Neethu Mariam Thomas, Rakendu N. Pramod, Ramesh Gondru & Janardhan Banothu. (2022) Coumarin – benzimidazole hybrids: A review on diverse synthetic strategies. Results in Chemistry 4, pages 100631.
Crossref
Crossref
Negar Omidkhah & Razieh Ghodsi. (2022) NO-HDAC dual inhibitors. European Journal of Medicinal Chemistry 227, pages 113934.
Crossref
Crossref
Madhuri Pandiri, Satheesh Kumar Nukala, Gouthami Dasari, Vinitha Badithapuram & Srinivas Bandari. (2021) Design and Synthesis of Some New N-Phenyl-[1,2,4]triazolo[4,3-a]quinoxaline-1-sulfonamide Derivatives and Their Anti-Cancer Activity. Russian Journal of General Chemistry 91:11, pages 2280-2285.
Crossref
Crossref
Atukuri Dorababu. (2021) Coumarin-heterocycle framework: A privileged approach in promising anticancer drug design. European Journal of Medicinal Chemistry Reports 2, pages 100006.
Crossref
Crossref
Ravikumar Reddy Sagam, Satheesh Kumar Nukala, Rajkumar Nagavath, Narsimha Sirassu, Prasad Gundepaka, Ravinder Manchal & Narasimha Swamy Thirukovela. (2021) In‐vitro Anticancer and Molecular Docking Studies of 4‐Azaindole‐1,2,4‐Oxadiazole Hybrids. ChemistrySelect 6:30, pages 7670-7673.
Crossref
Crossref
Kamila Buzun, Anna Kryshchyshyn-Dylevych, Julia Senkiv, Olexandra Roman, Andrzej Gzella, Krzysztof Bielawski, Anna Bielawska & Roman Lesyk. (2021) Synthesis and Anticancer Activity Evaluation of 5-[2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-thiazolidinones. Molecules 26:10, pages 3057.
Crossref
Crossref
Marta Szumilak, Anna Wiktorowska-Owczarek & Andrzej Stanczak. (2021) Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?. Molecules 26:9, pages 2601.
Crossref
Crossref
Prajwal Dhokne, Akash P. Sakla & Nagula Shankaraiah. (2021) Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances. European Journal of Medicinal Chemistry 216, pages 113334.
Crossref
Crossref
Madhu Sudhana Reddy Gangireddy, Manohar Mantipally, Vishnu Nayak Badavath, Venkatanarayana Chowdary Maddipati, Kalyani Paidikondala, Naresh Kumar Katari & Rambabu Gundla. (2021) Design, synthesis and molecular docking of piperidin‐4‐amine linked pyrimidine derivatives as potent anticancer agents. Chemical Data Collections 32, pages 100646.
Crossref
Crossref
Gloria Ana, Patrick M. Kelly, Azizah M. Malebari, Sara Noorani, Seema M. Nathwani, Brendan Twamley, Darren Fayne, Niamh M. O’Boyle, Daniela M. Zisterer, Elisangela Flavia Pimentel, Denise Coutinho Endringer & Mary J. Meegan. (2021) Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer. Pharmaceuticals 14:2, pages 169.
Crossref
Crossref
Bo Han, Xiang-Hong He, Yan-Qing Liu, Gu He, Cheng Peng & Jun-Long Li. (2021) Asymmetric organocatalysis: an enabling technology for medicinal chemistry. Chemical Society Reviews 50:3, pages 1522-1586.
Crossref
Crossref
Tadesse B. Tafesse, Mohammed H. Bule, Fazlullah Khan, Mohammad Abdollahi & Mohsen Amini. (2021) Developing Novel Anticancer Drugs for Targeted Populations: An Update. Current Pharmaceutical Design 27:2, pages 250-262.
Crossref
Crossref
Vidhya V. Jadvani & Yogesh T. Naliapara. (2021) Synthesis, Characterization and Antimicrobial Evaluation of Novel Dimethyl
Triazene Incorporated Phenylamino Pyrimidine Derivatives. Asian Journal of Organic & Medicinal Chemistry 6:3, pages 211-216.
Crossref
Crossref
Zhang-Xu He, Yun-Peng Gong, Xin Zhang, Li-Ying Ma & Wen Zhao. (2021) Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules. European Journal of Medicinal Chemistry 209, pages 112946.
Crossref
Crossref
Muhamad Mustafa, Ahmed El-Kardocy & Yaser A Mostafa. (2021) Development of new hetero-steroid hybrids with antiproliferative activity against MCF-7 breast cancer cells. Monatshefte für Chemie - Chemical Monthly 152:1, pages 137-149.
Crossref
Crossref
Deweshri R. Kerzare, Sunil S. Menghani, Nilesh R. Rarokar & Pramod B. Khedekar. (2020) Development of novel indole‐linked pyrazoles as anticonvulsant agents: A molecular hybridization approach. Archiv der Pharmazie 354:1, pages 2000100.
Crossref
Crossref
Ashraf K. El-Damasy, Md Mamunul Haque, Jung Woo Park, Sang Chul Shin, Jun-Seok Lee, Eunice EunKyeong Kim & Gyochang Keum. (2020) 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in vitro cell-based and oncogenic kinase assessments. European Journal of Medicinal Chemistry 208, pages 112756.
Crossref
Crossref
Rajitha Deshineni, Arya C G, Janardhan Banothu, Ravibabu Velpula & Gyanakumari Chellamella. (2020) Synthesis, anticancer and antibacterial evaluation of novel 1,3-disubstituted-1H-pyrazole-4-yl-methylene embedded fused thiazolo[2,3-b]quinazolinones. Chemical Data Collections 30, pages 100546.
Crossref
Crossref
Chenhao Xu, Wenjuan Zhou, Guanjun Dong, Hui Qiao, Jiadi Peng, Pengfei Jia, Yuhao Li, Hongmin Liu, Kai Sun & Wen Zhao. (2020) Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents. Bioorganic Chemistry 105, pages 104424.
Crossref
Crossref
Mennatallah A. Shaheen, Ali A. El-Emam & Nadia S. El-Gohary. (2020) Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M). Bioorganic Chemistry 105, pages 104274.
Crossref
Crossref
Eman T. Warda, Ihsan A. Shehata, Mahmoud B. El-Ashmawy & Nadia S. El-Gohary. (2020) New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation. Bioorganic & Medicinal Chemistry 28:21, pages 115674.
Crossref
Crossref
Parteek Prasher, Mousmee Sharma, Alaa A. A. Aljabali, Gaurav Gupta, Poonam Negi, Deepak N. Kapoor, Inderbir Singh, Flavia C. Zacconi, Terezinha de Jesus Andreoli Pinto, Mateus Webba da Silva, Hamid A. Bakshi, Dinesh Kumar Chellappan, Murtaza M. Tambuwala & Kamal Dua. (2020) Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review. Drug Development Research 81:7, pages 837-858.
Crossref
Crossref
Nermeen A. Qandeel, Ashraf K. El-Damasy, Maha H. Sharawy, Said M. Bayomi & Nadia S. El-Gohary. (2020) Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives. Bioorganic Chemistry 102, pages 103890.
Crossref
Crossref
Xiaodong Sun, Guohui Sun, Yaxin Huang, Yuxing Hao, Xiaoyu Tang, Na Zhang, Lijiao Zhao, Rugang Zhong & Yongzhen Peng. (2020) 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells. Biochemical Pharmacology 177, pages 113988.
Crossref
Crossref
Endika Martín-Encinas, Verónica Conejo-Rodríguez, Jesús A. Miguel, Jesús M. Martínez-Ilarduya, Gloria Rubiales, Birgitta R. Knudsen, Francisco Palacios & Concepción Alonso. (2020)
Novel phosphine sulphide gold(
i
) complexes: topoisomerase I inhibitors and antiproliferative agents
. Dalton Transactions 49:23, pages 7852-7861.
Crossref
Crossref
Davidson Barbosa Assis, Humberto de Carvalho Aragão Neto, Diogo Vilar da Fonsêca, Humberto Hugo Nunes de Andrade, Renan Marinho Braga, Nader Badr, Mayara dos Santos Maia, Ricardo Dias Castro, Luciana Scotti, Marcus Tullius Scotti & Reinaldo Nóbrega de Almeida. (2020) Antinociceptive Activity of Chemical Components of Essential Oils That Involves Docking Studies: A Review. Frontiers in Pharmacology 11.
Crossref
Crossref
Sharda Pasricha & Pragya Gahlot. (2020) Synthetic Strategies and Biological Potential of Coumarin-Chalcone Hybrids: A New Dimension to Drug Design. Current Organic Chemistry 24:4, pages 402-438.
Crossref
Crossref
Ramar Sivaramakarthikeyan, Shunmugam Iniyaval, Vadivel Saravanan, Wei-Meng Lim, Chun-Wai Mai & Chennan Ramalingan. (2020) Molecular Hybrids Integrated with Benzimidazole and Pyrazole Structural Motifs: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies. ACS Omega 5:17, pages 10089-10098.
Crossref
Crossref
Ahmed El-Harairy, Mennatallah Shaheen, Jun Li, Yuzhou Wu, Minghao Li & Yanlong Gu. (2020) Synthesis of α-indolylacrylates as potential anticancer agents using a Brønsted acid ionic liquid catalyst and the butyl acetate solvent. RSC Advances 10:23, pages 13507-13516.
Crossref
Crossref
Cristian C. Bernal, Luis C. Vesga, Stelia Carolina Mendez-Sánchez & Arnold R. Romero Bohórquez. (2020) Synthesis and anticancer activity of new tetrahydroquinoline hybrid derivatives tethered to isoxazoline moiety. Medicinal Chemistry Research 29:4, pages 675-689.
Crossref
Crossref
Andrea Petreni, Alessandro Bonardi, Carrie Lomelino, Sameh M. Osman, Zeid A. ALOthman, Wagdy M. Eldehna, Radwan El-Haggar, Robert McKenna, Alessio Nocentini & Claudiu T. Supuran. (2020) Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. European Journal of Medicinal Chemistry 190, pages 112112.
Crossref
Crossref
Koroush Mashayekh & Pezhman Shiri. (2019) An Overview of Recent Advances in the Applications of Click Chemistry in the Synthesis of Bioconjugates with Anticancer Activities. ChemistrySelect 4:46, pages 13459-13478.
Crossref
Crossref
N.S. El-Gohary, S.S. Hawas, M.T. Gabr, M.I. Shaaban & M.B. El-Ashmawy. (2019) New series of fused pyrazolopyridines: Synthesis, molecular modeling, antimicrobial, antiquorum-sensing and antitumor activities. Bioorganic Chemistry 92, pages 103109.
Crossref
Crossref
Khaled R.A. Abdellatif, Wael A.A. Fadaly, Yaser A. Mostafa, Dana M. Zaher & Hany A. Omar. (2019) Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities. Bioorganic Chemistry 91, pages 103132.
Crossref
Crossref
Endika Martín-Encinas, Gloria Rubiales, Birgitta R. Knudssen, Francisco Palacios & Concepción Alonso. (2019) Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones. European Journal of Medicinal Chemistry 178, pages 752-766.
Crossref
Crossref
Ana P. Francisco, Eduarda Mendes, Ana R. Santos & Maria J. Perry. (2019) Anticancer Triazenes: from Bioprecursors to Hybrid Molecules. Current Pharmaceutical Design 25:14, pages 1623-1642.
Crossref
Crossref
Manohar Mantipally, Madhusudhana Reddy Gangireddy, Rambabu Gundla, Vishnu Nayak Badavath, Santhosh Reddy Mandha & Venkatanarayana Chowdary Maddipati. (2019) Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2248-2253.
Crossref
Crossref
Jiliang Zhang, Shaojuan Zhang, Yang Liu, Meng Su, Xiaoxi Ling, Funan Liu, Yinghui Ge & Mingfeng Bai. (2018) Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer. Photodiagnosis and Photodynamic Therapy 24, pages 185-191.
Crossref
Crossref
Alaa A. Abd Elhameed, Nadia S. El-Gohary, Eman R. El-Bendary, Mona I. Shaaban & Said M. Bayomi. (2018) Synthesis and biological screening of new thiazolo[4,5-d]pyrimidine and dithiazolo[3,2-a:5′,4′-e]pyrimidinone derivatives as antimicrobial, antiquorum-sensing and antitumor agents. Bioorganic Chemistry 81, pages 299-310.
Crossref
Crossref
Aitor Maestro, Endika Martín-Encinas, Concepción Alonso, Edorta Martinez de Marigorta, Gloria Rubiales, Javier Vicario & Francisco Palacios. (2018) Synthesis of novel antiproliferative hybrid bis-(3-indolyl)methane phosphonate derivatives. European Journal of Medicinal Chemistry 158, pages 874-883.
Crossref
Crossref
Diana Lamaa, Hsin-Ping Lin, Lena Zig, Cyril Bauvais, Guillaume Bollot, Jérôme Bignon, Helene Levaique, Olivier Pamlard, Joelle Dubois, Mehdi Ouaissi, Martin Souce, Athena Kasselouri, François Saller, Delphine Borgel, Chantal Jayat-Vignoles, Hazar Al-Mouhammad, Jean Feuillard, Karim Benihoud, Mouad Alami & Abdallah Hamze. (2018)
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on
iso
-Combretastatin A-4
. Journal of Medicinal Chemistry 61:15, pages 6574-6591.
Crossref
Crossref
Ramesh Gondru, K Sirisha, Sneha Raj, Shravan Kumar Gunda, C Ganesh Kumar, Mukesh Pasupuleti & Rajitha Bavantula. (2018) Design, Synthesis, In Vitro Evaluation and Docking Studies of Pyrazole-Thiazole Hybrids as Antimicrobial and Antibiofilm Agents. ChemistrySelect 3:28, pages 8270-8276.
Crossref
Crossref
N.S. El-Gohary & M.I. Shaaban. (2018) New pyrazolopyridine analogs: Synthesis, antimicrobial, antiquorum-sensing and antitumor screening. European Journal of Medicinal Chemistry 152, pages 126-136.
Crossref
Crossref
Shalki Choudhary, Pankaj Kumar Singh, Himanshu Verma, Harpreet Singh & Om Silakari. (2018) Success stories of natural product-based hybrid molecules for multi-factorial diseases. European Journal of Medicinal Chemistry 151, pages 62-97.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
15
58
.
Shadia A. Galal, Muhammad Khattab, Samia A. Shouman, Raghda Ramadan, Omaima M. Kandil, Omnia M. Kandil, Ashraf Tabll, Yasmine S. El Abd, Reem El-Shenawy, Yasmin M. Attia, Ahmed A. El-Rashedy & Hoda I. El Diwani. (2018) Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates. European Journal of Medicinal Chemistry 146, pages 687-708.
Crossref
Crossref
Yun-Ta Lee, Feng-Yu Chiu, Indrajeet J. Barve & Chung-Ming Sun. (2018)
Microwave-Assisted Synthesis of Benzimidazole-Linked Indoline and Indole Hybrids from C-2 Linked (
o
-Aminobenzyl)benzimidazoles
. Advanced Synthesis & Catalysis 360:3, pages 502-512.
Crossref
Crossref
Jiabing Wang, Di Yun, Jiali Yao, Weitao Fu, Fangyan Huang, Liping Chen, Tao Wei, Cuijuan Yu, Haineng Xu, Xiaoou Zhou, Yanqing Huang, Jianzhang Wu, Peihong Qiu & Wulan Li. (2018) Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds. European Journal of Medicinal Chemistry 144, pages 493-503.
Crossref
Crossref
Alessio Nocentini, Silvia Bua, Carrie L. Lomelino, Robert McKenna, Marta Menicatti, Gianluca Bartolucci, Barbara Tenci, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Paola Gratteri & Claudiu T. Supuran. (2017) Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases. ACS Medicinal Chemistry Letters 8:12, pages 1314-1319.
Crossref
Crossref
Vinayak Botla, NavyaSree Pilli, Dhevendar Koude, Sunil Misra & Chandrasekharam Malapaka. (2017)
Molecular Engineering of Tetracyclic 2,3-Dihydro-1
H
-benzo[2,3]-benzofuro[4,5-e][1,3]oxazine Derivatives: Evaluation for Potential Anticancer Agents
. Archiv der Pharmazie 350:10, pages 1700169.
Crossref
Crossref
Ella Lineham, John Spencer & Simon J Morley. (2017) Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers. Future Medicinal Chemistry 9:13, pages 1539-1555.
Crossref
Crossref
Shadia A. Galal, Ahmed S. Abdelsamie, Samia A. Shouman, Yasmin M. Attia, Hamed I. Ali, Ashraf Tabll, Reem El-Shenawy, Yasmine S. El Abd, Mamdouh M. Ali, Abeer E. Mahmoud, Abeer H. Abdel-Halim, Amal A. Fyiad, Adel S. Girgis & Hoda I. El-Diwani. (2017) Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs. European Journal of Medicinal Chemistry 134, pages 392-405.
Crossref
Crossref
Chunmei Li & Furen Zhang. (2017) Efficient synthesis of novel furo[2,3-d]pyrimidine derivatives under catalyst-free conditions. Tetrahedron Letters 58:16, pages 1572-1575.
Crossref
Crossref
Guohui Sun, Tengjiao Fan, Lijiao Zhao, Yue Zhou & Rugang Zhong. (2017) The potential of combi-molecules with DNA-damaging function as anticancer agents. Future Medicinal Chemistry 9:4, pages 403-435.
Crossref
Crossref
Heba A.H. Elshemy & Mohamed A. Zaki. (2017) Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action. Bioorganic & Medicinal Chemistry 25:3, pages 1066-1075.
Crossref
Crossref
Rui Pinheiro, Cláudia Braga, Gisela Santos, Maria R. Bronze, Maria J. Perry, Rui Moreira, Dora Brites & Ana S. Falcão. (2016) Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?. ACS Chemical Neuroscience 8:1, pages 50-59.
Crossref
Crossref
M. Sambaiah, K. Raghavulu, K. Shiva Kumar, Satyanarayana Yennam & Manoranjan Behera. (2017) Synthesis of novel fused chromone–pyrimidine hybrids and 2,4,5-trisubstituted pyrimidine derivatives via ANRORC rearrangement. New Journal of Chemistry 41:18, pages 10020-10026.
Crossref
Crossref
Tomislav Gregorić, Mirela Sedić, Petra Grbčić, Andrea Tomljenović Paravić, Sandra Kraljević Pavelić, Mario Cetina, Robert Vianello & Silvana Raić-Malić. (2017) Novel pyrimidine-2,4-dione–1,2,3-triazole and furo[2,3-d]pyrimidine-2-one–1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation. European Journal of Medicinal Chemistry 125, pages 1247-1267.
Crossref
Crossref
Bishoy El-Aarag, Tomonari Kasai, Junko Masuda, Hussein Agwa, Magdy Zahran & Masaharu Seno. (2017) Anticancer effects of novel thalidomide analogs in A549 cells through inhibition of vascular endothelial growth factor and matrix metalloproteinase-2. Biomedicine & Pharmacotherapy 85, pages 549-555.
Crossref
Crossref
Qingjie Zhao & Guozheng Huang. 2017. Design of Hybrid Molecules for Drug Development. Design of Hybrid Molecules for Drug Development
193
218
.
Jayant Sindhu, Harjinder Singh, J. M. Khurana, Jitender Kumar Bhardwaj, Priyanka Saraf & Chetan Sharma. (2016) Synthesis and biological evaluation of some functionalized 1H-1,2,3-triazole tethered pyrazolo[3,4-b]pyridin-6(7H)-ones as antimicrobial and apoptosis inducing agents. Medicinal Chemistry Research 25:9, pages 1813-1830.
Crossref
Crossref
Dmytro Havrylyuk, Olexandra Roman & Roman Lesyk. (2016) Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline–thiazolidine-based hybrids. European Journal of Medicinal Chemistry 113, pages 145-166.
Crossref
Crossref
Riham F. George, Marwa A. Fouad & Iman E.O. Gomaa. (2016) Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers. European Journal of Medicinal Chemistry 112, pages 48-59.
Crossref
Crossref
Saadia Leeza Zaidi, Subhash M. Agarwal, Porntip Chavalitshewinkoon-Petmitr, Thidarat Suksangpleng, Kamal Ahmad, Fernando Avecilla & Amir Azam. (2016) Thienopyrimidine sulphonamide hybrids: design, synthesis, antiprotozoal activity and molecular docking studies. RSC Advances 6:93, pages 90371-90383.
Crossref
Crossref
Han Wei, Jinlan Ruan & Xiaojian Zhang. (2016) Coumarin–chalcone hybrids: promising agents with diverse pharmacological properties. RSC Advances 6:13, pages 10846-10860.
Crossref
Crossref
Atulya Nagarsenkar, Santosh Kumar Prajapti, Sravanthi Devi Guggilapu, Swetha Birineni, Sudha Sravanti Kotapalli, Ramesh Ummanni & Bathini Nagendra Babu. (2016) Investigation of triazole-linked indole and oxindole glycoconjugates as potential anticancer agents: novel Akt/PKB signaling pathway inhibitors. MedChemComm 7:4, pages 646-653.
Crossref
Crossref
Surendra R. Punganuru, Hanumantha Rao Madala, Sanjay N. Venugopal, Ramakrishna Samala, Constantinos Mikelis & Kalkunte S. Srivenugopal. (2016) Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties. European Journal of Medicinal Chemistry 107, pages 233-244.
Crossref
Crossref
Temilolu Idowu, Pranati Samadder, Gilbert Arthur & Frank Schweizer. (2016) Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids. Chemistry and Physics of Lipids 194, pages 139-148.
Crossref
Crossref
Jure Vajs, Ivana Steiner, Anamaria Brozovic, Andrej Pevec, Andreja Ambriović-Ristov, Marija Matković, Ivo Piantanida, Damijana Urankar, Maja Osmak & Janez Košmrlj. (2015) The 1,3-diaryltriazenido(p-cymene)ruthenium(II) complexes with a high in vitro anticancer activity. Journal of Inorganic Biochemistry 153, pages 42-48.
Crossref
Crossref
Stavros E. Bariamis, George E. Magoulas, Katerina Grafanaki, Eleni Pontiki, Theodore Tsegenidis, Constantinos M. Athanassopoulos, George Maroulis, Dionissios Papaioannou & Dimitra Hadjipavlou-Litina. (2015) Synthesis and biological evaluation of new C-10 substituted dithranol pleiotropic hybrids. Bioorganic & Medicinal Chemistry 23:22, pages 7251-7263.
Crossref
Crossref
Rahmi Kasımoğulları, Hamdiye Duran, Ayşe Şahin Yağlıoğlu, Samet Mert & İbrahim Demirtaş. (2015) Design, synthesis, characterization, and antiproliferative activity of novel pyrazole-3-carboxylic acid derivatives. Monatshefte für Chemie - Chemical Monthly 146:10, pages 1743-1749.
Crossref
Crossref
Vandana Srivastava & Hoyun Lee. (2015) Chloroquine-based hybrid molecules as promising novel chemotherapeutic agents. European Journal of Pharmacology 762, pages 472-486.
Crossref
Crossref
T. Srinivasa Reddy, Hitesh Kulhari, V. Ganga Reddy, Vipul Bansal, Ahmed Kamal & Ravi Shukla. (2015) Design, synthesis and biological evaluation of 1,3-diphenyl-1 H -pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. European Journal of Medicinal Chemistry 101, pages 790-805.
Crossref
Crossref
Loana Musso, Sabrina Dallavalle & Franco Zunino. (2015) Perspectives in the development of hybrid bifunctional antitumour agents. Biochemical Pharmacology 96:4, pages 297-305.
Crossref
Crossref
Paula Morales, Sandra Blasco-Benito, Clara Andradas, María Gómez-Cañas, Juana María Flores, Pilar Goya, Javier Fernández-Ruiz, Cristina Sánchez & Nadine Jagerovic. (2015)
Selective, Nontoxic CB
2
Cannabinoid
o
-Quinone with in Vivo Activity against Triple-Negative Breast Cancer
. Journal of Medicinal Chemistry 58:5, pages 2256-2264.
Crossref
Crossref
Li-Ying Ma, Bo Wang, Lu-Ping Pang, Miao Zhang, Sai-Qi Wang, Yi-Chao Zheng, Kun-Peng Shao, Deng-Qi Xue & Hong-Min Liu. (2015) Design and synthesis of novel 1,2,3-triazole–pyrimidine–urea hybrids as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters 25:5, pages 1124-1128.
Crossref
Crossref
Anil Rana, Jimi Marin Alex, Monika Chauhan, Gaurav Joshi & Raj Kumar. (2014) A review on pharmacophoric designs of antiproliferative agents. Medicinal Chemistry Research 24:3, pages 903-920.
Crossref
Crossref
Melanie Lödige & Luisa Hiersch. (2015) Design and Synthesis of Novel Hybrid Molecules against Malaria. International Journal of Medicinal Chemistry 2015, pages 1-23.
Crossref
Crossref
A N Tevyashova, E N Olsufyeva & M N Preobrazhenskaya. (2015) Design of dual action antibiotics as an approach to search for new promising drugs. Russian Chemical Reviews 84:1, pages 61-97.
Crossref
Crossref
K. Easwaramoorthi, A. Jeya Rajendran, K. Chennakesava Rao, Y. Arun, C. Balachandran, P. T. Perumal, Nobuhiko Emi, S. M. Mahalingam, V. Duraipandiyan & N. A. Al-Dhabi. (2015) Synthesis of novel 1,4-disubstituted 1,2,3-triazolo-bosentan derivatives – evaluation of antimicrobial and anticancer activities and molecular docking. RSC Advances 5:127, pages 105266-105278.
Crossref
Crossref
Li-Ying Ma, Lu-Ping Pang, Bo Wang, Miao Zhang, Biao Hu, Deng-Qi Xue, Kun-Peng Shao, Bao-Le Zhang, Ying Liu, En Zhang & Hong-Min Liu. (2014) Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents. European Journal of Medicinal Chemistry 86, pages 368-380.
Crossref
Crossref
Bishoy Y.A. El-Aarag, Tomonari Kasai, Magdy A.H. Zahran, Nadia I. Zakhary, Tsukasa Shigehiro, Sreeja C. Sekhar, Hussein S. Agwa, Akifumi Mizutani, Hiroshi Murakami, Hiroki Kakuta & Masaharu Seno. (2014) In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs. International Immunopharmacology 21:2, pages 283-292.
Crossref
Crossref
Romeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, Mariem Chayah, M. Encarnacion Camacho, Filippo Prencipe, Ernest Hamel, Francesca Consolaro, Giuseppe Basso & Giampietro Viola. (2014) Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agents. European Journal of Medicinal Chemistry 81, pages 394-407.
Crossref
Crossref
Kunal Nepali, Sahil Sharma, Manmohan Sharma, P.M.S. Bedi & K.L. Dhar. (2014) Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. European Journal of Medicinal Chemistry 77, pages 422-487.
Crossref
Crossref
Tamilselvan Rajasekaran, Govindaraju Karthik, B. Sridhar, S. Kiran Kumar & Basi V. Subba Reddy. (2014) Highly Diastereoselective Reaction of α‐Diazoesters with Aryl Alcohols and Isatin Imines: Rapid Access to Oxindole‐Derived α‐Alkoxy‐β‐amino Acid Derivatives with Two Adjacent Quaternary Carbon Centers. European Journal of Organic Chemistry 2014:11, pages 2221-2224.
Crossref
Crossref
Samet Mert, Ayşe Şahin Yağlıoğlu, Ibrahim Demirtas & Rahmi Kasımoğulları. (2013) Synthesis and antiproliferative activities of some pyrazole-sulfonamide derivatives. Medicinal Chemistry Research 23:3, pages 1278-1289.
Crossref
Crossref
Soundararasu Senthilkumar, Sure Siva Prasad, Ponminor Senthil Kumar & Sundarababu Baskaran. (2014) A diversity oriented one-pot synthesis of novel iminosugar C-glycosides. Chemical Communications 50:13, pages 1549.
Crossref
Crossref
Paula Morales, Diana Vara, María Goméz-Cañas, María C. Zúñiga, Claudio Olea-Azar, Pilar Goya, Javier Fernández-Ruiz, Inés Díaz-Laviada & Nadine Jagerovic. (2013) Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity. European Journal of Medicinal Chemistry 70, pages 111-119.
Crossref
Crossref
Ying-Chao Duan, Yi-Chao Zheng, Xiao-Chen Li, Meng-Meng Wang, Xian-Wei Ye, Yuan-Yuan Guan, Gai-Zhi Liu, Jia-Xin Zheng & Hong-Min Liu. (2013) Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole–dithiocarbamate–urea hybrids. European Journal of Medicinal Chemistry 64, pages 99-110.
Crossref
Crossref
L. W. Lawrence Woo, Paul M. Wood, Christian Bubert, Mark P. Thomas, Atul Purohit & Barry V. L. Potter. (2013)
Synthesis and Structure–Activity Relationship Studies of Derivatives of the Dual Aromatase–Sulfatase Inhibitor 4‐{[(4‐Cyanophenyl)(4
H
‐1,2,4‐triazol‐4‐yl)amino]methyl}phenyl sulfamate
. ChemMedChem 8:5, pages 779-799.
Crossref
Crossref
Makoah N. Aminake, Aman Mahajan, Vipan Kumar, Renate Hans, Lubbe Wiesner, Dale Taylor, Carmen de Kock, Anne Grobler, Peter J. Smith, Marc Kirschner, Axel Rethwilm, Gabriele Pradel & Kelly Chibale. (2012) Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy. Bioorganic & Medicinal Chemistry 20:17, pages 5277-5289.
Crossref
Crossref
Gonzalo García, Isabel Serrano, Patricia Sánchez-Alonso, Manuel Rodríguez-Puyol, Ramón Alajarín, Mercedes Griera, Juan J. Vaquero, Diego Rodríguez-Puyol, Julio Álvarez-Builla & María L. Díez-Marqués. (2012) New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers. European Journal of Medicinal Chemistry 50, pages 90-101.
Crossref
Crossref
Weihu Shang, Jinping Qiao, Chenxin Gu, Wei Yin, Jinglei Du, Wei Wang, Meilin Zhu, Mei Han & Weidong Lu. (2011) Anticancer activity of an extract from needles and twigs of Taxus cuspidata and its synergistic effect as a cocktail with 5-fluorouracil. BMC Complementary and Alternative Medicine 11:1.
Crossref
Crossref
Gamal A. Elmegeed, Wagdy K.B. Khalil, Rafat M. Mohareb, Hanaa H. Ahmed, Mervat M. Abd-Elhalim & Ghada H. Elsayed. (2011) Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents. Bioorganic & Medicinal Chemistry 19:22, pages 6860-6872.
Crossref
Crossref
Nouri Neamati. 2011. HIV‐1 Integrase. HIV‐1 Integrase
165
196
.
L.W. Lawrence Woo, Atul Purohit & Barry V.L. Potter. (2011) Development of steroid sulfatase inhibitors. Molecular and Cellular Endocrinology 340:2, pages 175-185.
Crossref
Crossref
Alicia Merlino, Lucia Otero, Dinorah Gambino & E. Laura Coitiño. (2011) In search of patterns over physicochemical properties and pharmacological activities for a set of [MCl2(thiosemicarbazone)] complexes (M=Pt/Pd): Support for multiple mechanisms of antichagasic action excluding DNA-bonding in vivo?. European Journal of Medicinal Chemistry 46:7, pages 2639-2651.
Crossref
Crossref
John Spencer, Jahangir Amin, Minghua Wang, Graham Packham, Sharifah S. Syed Alwi, Graham J. Tizzard, Simon J. Coles, Ronald M. Paranal, James E. Bradner & Tom D. Heightman. (2011) Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors. ACS Medicinal Chemistry Letters 2:5, pages 358-362.
Crossref
Crossref
L. W. Lawrence Woo, Christian Bubert, Atul Purohit & Barry V. L. Potter. (2010) Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity. ACS Medicinal Chemistry Letters 2:3, pages 243-247.
Crossref
Crossref
Jérémy Ricci, Minkyu Kim, Won-Yoon Chung, Kwang-Kyun Park & Mankil Jung. (2011) Discovery of Artemisinin-Glycolipid Hybrids as Anti-oral Cancer Agents. CHEMICAL & PHARMACEUTICAL BULLETIN 59:12, pages 1471-1475.
Crossref
Crossref
Jérémy Ricci, Jeehyun Park, Won-Yoon Chung, Kwang-Kyun Park & Mankil Jung. (2010) Concise synthesis and antiangiogenic activity of artemisinin–glycolipid hybrids on chorioallantoic membranes. Bioorganic & Medicinal Chemistry Letters 20:22, pages 6858-6860.
Crossref
Crossref
L. W. Lawrence WooToby JacksonAurélien PuteyGyles CozierPhilip LeonardK. Ravi AcharyaSurinder K. ChanderAtul PurohitMichael J. ReedBarry V. L. Potter. (2010) Highly Potent First Examples of Dual Aromatase−Steroid Sulfatase Inhibitors based on a Biphenyl Template. Journal of Medicinal Chemistry 53:5, pages 2155-2170.
Crossref
Crossref